| Execution period | Valid until 03/04/2031 |
|---|
NSE filing, NSE: PRIMECAB. Summary written from the filing by ALFA Finder's alert engine.
Prime Cable Industries Ltd: key numbers
- Share price
- ₹176.75
- Market cap
- ₹323.9 Cr
- Revenue (annual)
- ₹234.9 Cr
- Net profit (annual)
- ₹12.24 Cr
- P/E (TTM)
- 26.5×Sector 41.2×
- Promoter holding
- 68.47%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prime Cable Industries Ltd
All →Prime Cable Industries Bags ₹12.98 Cr Order from Reputed listed EPC
Prime Cable Industries received a ₹12.98 Crore purchase order from a listed EPC for LT cable supply. Execution is due in 6 months; no related-party interest.
- Value
- ₹12.98 Cr
- From
- Reputed listed EPC (unnamed)
- Execution
- 6 Months
Prime Cable Industries Other Announcement
Prime Cable Industries replaced its NSE Emerge market maker, appointing NDA Securities effective 14 Oct 2026. Alacrity Securities' resignation takes effect 13 Oct 2026.
Prime Cable Industries Business Update
Prime Cable Industries Limited has appointed NDA Securities Limited as its new Market Maker for equity shares on NSE Emerge, replacing Alacrity Securities Limited.
Prime Cable Industries Annual General Meeting
Prime Cable Industries Limited conducted its 18th Annual General Meeting on September 30, 2026. Shareholders approved financial statements and increases in managerial remuneration for the company's directors.
Prime Cable Industries Bags ₹16.49 Cr Order from A reputed Indian listed company
Prime Cable Industries Limited received a ₹16.49 Crore order for 11 KV MV cables from a reputed listed company. The contract execution period is 4 months.
- Value
- ₹16.49 Cr
- From
- A reputed Indian listed company
- Execution
- 4 Months
Prime Cable Industries Other Announcement
Prime Cable Industries Limited has received a renewed NABL Accreditation for its Quality Assurance Laboratory, valid until August 2030, with an expanded scope for cable testing.
Other regulatory approval announcements
All →Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
RNFI Services Regulatory Approval
RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.
Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.
Elantas Beck India Regulatory Approval
Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.